Meeting
2023 ASCO Genitourinary Cancers Symposium
Oncological outcome of intraarterial chemotherapy combined with radiotherapy compared to radical cystectomy for patients with muscle invasive bladder cancer.
Authors
Katsuyoshi Higashijima
Department of Urology,University of Occupational and Environmental Health, Kitakyushu, Japan
Katsuyoshi Higashijima , Ikko Tomisaki , Akinori Minato , Kenichi Harada , Naohiro Fujimoto
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer - Advanced
Sub Track
Therapeutics
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 515)
DOI
10.1200/JCO.2023.41.6_suppl.515
Abstract #
515
Poster Bd #
K19
Abstract Disclosures
Similar Posters
Poster
2017 Genitourinary Cancers Symposium
Investigation on relationships between reduction of cisplatin and anticancer effects in patients with bladder cancer.
First Author: Yasuyoshi Miyata
Poster
2014 Genitourinary Cancers Symposium
Radical cystectomy versus trimodality bladder-preserving therapy for muscle-invasive bladder cancer among elderly (80-84 years old) patients.
First Author: Shingo Hatakeyama
Poster
2013 ASCO Annual Meeting
Randomized phase III trial of neoadjuvant chemotherapy (NAC) with methotrexate, doxorubicin, vinblastine, and cisplatin (MVAC) followed by radical cystectomy (RC) compared with RC alone for muscle-invasive bladder cancer (MIBC): Japan Clinical Oncology Group study, JCOG0209.
First Author: Hiroshi Kitamura
Poster
2024 ASCO Genitourinary Cancers Symposium
Characteristics, treatment patterns, and clinical outcomes of patients undergoing neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer in the real world.
First Author: Patrick Squires